Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Akamatsu

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
The Journal of Biological Chemistry|December 10, 1999
Vinexin forms a signaling complex with Sos and modulates epidermal growth factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activitiesM Akamatsu, S Aota, A Suwa, et al.
Human Pathology|June 1, 1995
CD30-positive anaplastic large cell lymphoma in a human T-cell lymphotropic virus-I endemic areaM Takeshita, K Ohshima, M Akamatsu, et al.
Human Pathology|December 1, 1995
Angiocentric immunoproliferative lesions of the skin show lobular panniculitis and are mainly disorders of large granular lymphocytesM Takeshita, M Akamatsu, K Ohshima, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 5, 2002
[Percutaneous hepatic infarction therapy (PIT)]M Imamura, S Shiina, T Teratani, et al.
Journal of Medicinal Chemistry|October 13, 1995
L-O-(2-malonyl)tyrosine: a new phosphotyrosyl mimetic for the preparation of Src homology 2 domain inhibitory peptidesB Ye, M Akamatsu, S E Shoelson, et al.
Histopathology|December 1, 1994
Heterogeneity of Epstein-Barr virus infection in angioimmunoblastic lymphadenopathy type T-cell lymphomaK Ohshima, H Takeo, M Kikuchi, et al.
Transplantation Proceedings|February 1, 1995
Effect of rescue therapy using FK 506 on relapsing rejection after combined pancreas and kidney transplantationS Teraoka, T Babazono, T Koike, et al.
Journal of Medicinal Chemistry|March 1, 1996
4'-O-[2-(2-fluoromalonyl)]-L-tyrosine: a phosphotyrosyl mimic for the preparation of signal transduction inhibitory peptidesT R Burke, B Ye, M Akamatsu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 4, 2000
[Percutaneous tumor ablation therapy for the advanced stage of HCC]T Teratani, S Shiina, S Obi, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 5, 2002
[Management of complications associated with local ablation therapy for hepatocellular carcinoma]S Obi, S Shiina, M Imamura, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
The Journal of Biological Chemistry|December 10, 1999
Vinexin forms a signaling complex with Sos and modulates epidermal growth factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activitiesM Akamatsu, S Aota, A Suwa, et al.
Human Pathology|June 1, 1995
CD30-positive anaplastic large cell lymphoma in a human T-cell lymphotropic virus-I endemic areaM Takeshita, K Ohshima, M Akamatsu, et al.
Human Pathology|December 1, 1995
Angiocentric immunoproliferative lesions of the skin show lobular panniculitis and are mainly disorders of large granular lymphocytesM Takeshita, M Akamatsu, K Ohshima, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 5, 2002
[Percutaneous hepatic infarction therapy (PIT)]M Imamura, S Shiina, T Teratani, et al.
Journal of Medicinal Chemistry|October 13, 1995
L-O-(2-malonyl)tyrosine: a new phosphotyrosyl mimetic for the preparation of Src homology 2 domain inhibitory peptidesB Ye, M Akamatsu, S E Shoelson, et al.
Histopathology|December 1, 1994
Heterogeneity of Epstein-Barr virus infection in angioimmunoblastic lymphadenopathy type T-cell lymphomaK Ohshima, H Takeo, M Kikuchi, et al.
Transplantation Proceedings|February 1, 1995
Effect of rescue therapy using FK 506 on relapsing rejection after combined pancreas and kidney transplantationS Teraoka, T Babazono, T Koike, et al.
Journal of Medicinal Chemistry|March 1, 1996
4'-O-[2-(2-fluoromalonyl)]-L-tyrosine: a phosphotyrosyl mimic for the preparation of signal transduction inhibitory peptidesT R Burke, B Ye, M Akamatsu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 4, 2000
[Percutaneous tumor ablation therapy for the advanced stage of HCC]T Teratani, S Shiina, S Obi, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 5, 2002
[Management of complications associated with local ablation therapy for hepatocellular carcinoma]S Obi, S Shiina, M Imamura, et al.
Pageof 8